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ABSTRACT 
 
Polymeric micelles in nanomedicine are often crosslinked to prevent disintegration in vivo. 
This typically requires clinically problematic chemicals or laborious procedures. In addition, 
crosslinking may interfere with advanced release strategies. Despite this, it is often not 
investigated whether crosslinking is necessary for efficient drug delivery. We used PET 
imaging with 
64
Cu to demonstrate general methodology for real-time in vivo investigations of 
micelle stability. Triblock copolymers with 4-methylcoumarin cores of ABC-type (PEG-
PHEMA-PCMA) were functionalized in the handle region (PHEMA) with CB-TE2A 
chelators. Polymeric micelles were formed by dialysis and one half was core-crosslinked by 
UV light (CL) and the other half was not (nonCL). Both CL and nonCL were radiolabeled 
with 
64
Cu and compared in vivo in tumor-bearing mice, with free 
64
Cu as control. 
Accumulation in relevant organs was quantified by ROI analysis on PET images and ex vivo 
counting. It was observed that CL and nonCL showed limited differences in biodistribution 
from each other, whereas both differed markedly from control (free 
64
Cu). This demonstrated 
that 4-methylcoumarin core micelles may form micelles that are stable in circulation even 
without crosslinking. The methodology presented here where individual unimers are 
radiolabeled is applicable to a wide range of polymeric micelle types. 
 
1 Introduction 
 
Polymeric micelles (PMs) are nanoparticles composed of linear, synthetic monomers that 
contain several chemically distinct domains known as blocks.
1
 Usually di- or triblock 
micelles are prepared, where the triblock variety may contain 1) a hydrophobic domain 
making up the core, 2) a handle domain that can be chemically functionalized, and 3) a 
hydrophilic domain that faces the surrounding aqueous medium (Figure 1). Such monomers 
can self-assemble into nanostructures that can be engineered to exhibit a wide range of sizes 
(usually 5 – 100 nm) and to be highly synthetically versatile. Polymeric micelles can 
accumulate in tumors through the enhanced permeation and retention (EPR) effect
2
 and have 
potential as drug delivery systems, in particular by covalently binding drug molecules 
through labile bonds that can break at the desired site of action.
3,4
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The stability of polymeric micelles is in part determined by the critical micelle concentration 
(CMC). This number denotes the maximum concentration at thermodynamic equilibrium at 
which single monomers can exist freely in aqueous solution, and hence at which point they 
will start to form micelles. In circulation, polymeric micelles may disintegrate due to dilution 
below the CMC, as well as by interactions with blood-born proteins that shift the equilibrium 
towards the unimer state.
1
 This causes possible release of drug molecules and the abrogation 
of the desirable nanoparticulate properties of the micelles. In order to circumvent this, the 
monomers of polymeric micelles have been crosslinked by a multitude of methods, in order 
to create an integral nanoparticle. These have included amide formation,
5
 polymerization 
reactions
6,7
,
 
UV-induced initiator-mediated photo-crosslinking
8,9
 as well as more exotic 
methods.
10,11
 Reversible crosslinking strategies have been devised as a manner in which to 
control the release of cargo drug molecules, once accumulation at target sites has been 
achieved. This has been achieved using disulfide bonds,
12
 cleavable imine linkages
13
 and 
direct dimerization of core coumarin moieties through irradiation with ultraviolet light.
14
 This 
latter strategy is known as photo core crosslinking (PCCL) and has the immediate advantage 
that no addition of reactive chemicals, initiators or purification steps are necessary. Coumarin 
undergoes 2+2 photodimerization to a cyclobutane ring when exposed to UV light of λ > 310 
nm. If irradiated at λ < 260 nm, the ring is cleaved, refurnishing the two coumarin moieties as 
separate molecules. The chemical properties of coumarin as a reversibly dimerizable 
compound were excellently reviewed by Trenor et al.
15
 and its applications by He et al.
16
 As 
the crosslinkable carbon‐carbon double bond of coumarin absorbs light around 320 nm, the 
degree of crosslinking can be assessed by measuring the drop in absorbance at this 
wavelength. As coumarin with a methyl group in the 4‐position exhibits faster dimerization 
rates than other coumarin derivates
17
, 4-methyl coumarin is often employed in micelle 
crosslinking.
14,18 
 
When investigating crosslinking strategies, it is important to evaluate the stability of the 
resulting polymeric micelles against their non-crosslinked counterparts. As non-crosslinked 
PMs may have certain advantages, such as easier renal excretion and easier preparation, there 
is a rationale in not crosslinking unless the benefits are well-documented. A useful technique 
for investigating such key in vivo properties of nanoparticles is labeling with positron-
emitting radionuclides and imaging by positron emission tomography (PET). PET is based on 
the coincidence detection of positrons from positron-electron annihilation and is a truly 
quantitative technique which offers excellent sensitivity and spatial resolution. When imaging 
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nanoparticles in murine models, an especially useful radionuclide is copper-64 (
64
Cu, T½ = 
12.7 h), which offers an imaging window of up to 48-72 hours and thereby adequately covers 
the distribution phase of long-circulating PMs. Association of 
64
Cu to nanoparticles is 
typically achieved by complexation in a covalently bound chelator molecule. The 
crossbridged, macrocyclic chelator 2,2'-(1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-4,11-
diyl)diacetic acid (CB-TE2A) has been reported on several occasions to exhibit excellent 
serum and blood stream stability and is generally considered to be a highly reliable chelator 
for 
64
Cu.
19,20,21 
  
In the study at hand we employed in vivo PET imaging to investigate the difference in 
biodistribution between a crosslinked and a non-crosslinked version of two identical triblock 
coumarin-core polymeric micelles radiolabeled with 
64
Cu through CB-TE2A. The CB-TE2A 
was conjugated to the middle block, where it would be shielded from interaction with in vivo 
components by the outermost polyethylene glycol (PEG)-layer, limiting the effects the 
chelate may have on the biodistribution of the micelles.   
 
  
 
 
2 Experimental 
 
2.1 Materials 
 
CB-TE2A·2H2O was purchased from Macrocyclics. All further chemicals and solvents were 
from Sigma-Aldrich. For anhydrous syntheses, dimethylformamide (DMF) was dried over 
4Å molecular sieves and all glassware was oven-dried overnight or heatgun-dried prior to 
use. Reactions were carried out under a nitrogen atmosphere and polymers and micelles 
containing coumarin moieties were shielded from light whenever possible. Cellulose 
membrane dialysis tubing (12.4 kDa cutoff) was from Sigma Aldrich. Size-exclusion 
chromatography (SEC) was carried out on custom-built automated equipment, using 
Sephadex G25 “fine” (GE Healthcare, fractionation range: 1000-5000 Da) as stationary phase 
and 10 mM piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) buffer (pH 7.0, 150 mM 
NaCl) as eluent, flow rate of 0.5 mL/min, room temperature and column dimensions of 20 × 
1.5 cm. Photo cross-linking by UV irradiation was done on an Omnicure Series 1000 (Lumen 
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Dynamics). UV−VIS spectra were recorded on a Unicam Helios Uni 4923 
spectrophotometer. Size and zeta potential were measured on a Brookhaven ZetaPALS. 
64
Cu 
was produced on a GE PETtrace Cyclotron. Radio-TLCs were analyzed on a Raytest 
MiniGita Star and eluted with 5% (w/v) NH4OAc in H2O-MeOH (1:1). Rf of 
64
Cu-EDTA: 
0.7 (EDTA: ethylenediaminetetraacetic acid), Rf of 
64
Cu-CB-TE2A: 0.3.  
 
 
2.2 Preparation of CB-TE2A conjugated polymeric micelles 
  
The synthesis and micellization of CB-TE2A conjugated polyethylene glycol-
polyhydroxyethyl methacrylate-polymethacryloyloxyethoxy-4-methylcoumarin (PEG-
PHEMA-PCMA) unimers was carried out as previously reported by isolated macroinitiator 
atomic transfer radical polymerization (ATRP) (Figure 1).
22
 In brief, the PEG-PHEMA-Cl 
block copolymer was synthesized according to a literature procedure
23
 and it was used as 
macroinitiator for the synthesisis of the 4-methylcoumarin block. The resulting triblock 
copolymer PEG-PHEMA-PCMA was precipitated from methanol and dried under vacuum. 
Copper residues and residual impurities were removed by dialysis (molecular weight cut-off 
= 12 kDa). CB-TE2A was conjugated by ester bonds to the primary alcohols of the PHEMA 
block through 4-dimethylaminopyridine (DMAP)-catalyzed 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) coupling in DMF. The micelles were 
subsequently formed by dialysis with water.   
 
 
2.3 Crosslinking of micelles 
 
Micelle dispersions (1100 µL) were transferred to a 4 mL glass vial which was placed in a 
water-ice bath kept at 5-7 
o
C. Under vigorous magnetic stirring, the dispersions were 
irradiated with UV light for 2 x 15 minutes at an intensity of 2 W/cm
2 
and a wavelength of 
320 < λ < 500 nm. The UV probe was placed above the water surface at a distance of about a 
centimeter. The degree of crosslinking (%CL) was determined by measuring the drop in 
absorbance (A) at 320 nm and calculating: ((Abefore − Aafter)/(Abefore – A0)) × 100% = %CL, 
where A0 was set to zero.
24
  
 
 
  
This article is protected by copyright. All rights reserved. 
2.4 Radiolabeling 
 
To a vial containing dried 
64
CuCl2 was added aqueous NH4OAc (100 µL, 0.1 M, pH 5.5), 
followed by magnetic stirring at room temperature for 10 minutes. Then was added 
crosslinked (CL) or non-crosslinked (nonCL) PM dispersions (400 µL, ~4 mg/mL) and the 
mixtures were stirred for 3 hours at 80 
o
C. After radiolabeling, non-incorporated 
64
Cu was 
scavenged by immediate addition of aqueous EDTA (50 µL, 1 mM) followed by stirring for 
20 minutes. The radiolabeled PMs were then separated from 
64
Cu-EDTA by automated size-
exclusion chromatography using Sephadex 25 as stationary phase and isotonic PIPES buffer 
(10 mM PIPES, 150 mM NaCl, pH 7.0) as eluent. From the fractions making up the large-
molecules peak (containing the PMs) a total volume of 1 mL which contained the highest 
concentration of radioactivity was collected and used for in vivo studies. 
 
 
2.5 Characterization of micelles 
 
Micelles were characterized by dynamic light scattering (DLS), providing hydrodynamic 
diameter, polydispersity index (PDI) and zeta-potential. Size was measured three times on the 
same sample, unless otherwise stated, and were reported as nr. weighted medians based on 
normal distributions. Zeta-potentials were measured by running 20 runs of 10 scans on one 
sample, unless otherwise specified. The concentration of micelle material in dispersion was 
determined by measuring absorption of UV light at 320 nm in non-crosslinked dispersions. 
This value was compared to the absorption of dispersions that had been subsequently 
lyophilized to determine the amount of micelle material.  
 
 
2.6 Formulation of 
64
CuCl2 for control experiment 
 
To a vial containing dried 
64
CuCl2 was added a solution of NH4OAc in saline (2.3 mL, 
NH4OAc: 10 mM, NaCl: 150 mM, pH = 6.4). The mixture was magnetically stirred for 30 
minutes at 55
o
C and used for injection after cooling to room temperature.    
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2.7 In vivo PET/CT studies 
 
All animal experiments were approved by the Danish Animal Welfare Council, Ministry of 
Environment & Food. Seven weeks old female NMRI nude mice purchased from Tarconic 
(Borup, Denmark) were inoculated in the right and left flank with 5*10
6
 U87MG cells (LGC 
standards, Boras, Sweden) in a 1:1 mixture with matrixgel™ (BD Biosciences, Albertslund, 
Denmark). Tumors were allowed to grow for 2 weeks giving tumor sizes of 133 ± 79.9 mm
3 
(mean ± SD). The mice were divided into three groups; CL (n = 6) nonCL (n = 5) and free 
64
Cu (n = 5). The CL group has previously been published.
22
 Either of the three solutions 
were intravenously injected in a lateral tail vein of anesthetized mice at an average dose of 
7.8 ± 0.46 MBq (mean ± SD) for the CL micelles, 8.9 ± 0.35 MBq for the nonCL‐micelles 
and 10.5 ± 0.91 MBq for the free 
64
Cu at a volume of 200 μL. The PET/CT scans were 
acquired on dedicated small animal systems (all PET acquisitions on the MicroPET Focus 
120, and CT acquisitions on either the MicroCAT® II or the Inveon PET/CT system, 
Siemens Medical Solutions, Malvern, PA, USA) at 1h, 22h and 46h post injection (p.i.) with 
PET acquisition times of 10, 15 & 30 min. respectively. PET data were reconstructed with the 
2‐dimentional ordered‐subset expectation maximization (OSEM2D) reconstruction 
algorithm. PET and CT images were analyzed as fused images using the Inveon software 
(Siemens) where regions of interest (ROIs) were drawn around liver, kidney, spleen, muscle, 
tumors and the left‐ventricle. Uptake in the left ventricle of the heart was taken as a measure 
of the blood concentration. CT settings were a tube voltage of 64 kVp, a tube current of 500 
μA, 360 rotation steps, an exposure time of 440 ms and a voxel size of 0.092 mm on the 
MicroCAT® II system and a tube voltage of 65 kVp, a tube current of 500 μA, 181 rotation 
steps, an exposure time of 400 ms and a voxel size of 0.105 mm on the Inveon PET/CT 
system. Immediately following the last PET scan, mice were euthanized and blood as well as 
organs of interest collected and counted in a gamma counter (Perkin Elmer Life Sciences). 
The statistics were calculated using Excel 2010. Differences between groups were analyzed 
using an unpaired, two‐tailed t‐test.. A p‐value < 0.05 was considered significant. Error bars 
on tracer accumulation (%ID/g) are presented as standard deviations (SD). 
 
 
 
 
  
This article is protected by copyright. All rights reserved. 
3 Results & discussion 
 
3.1 Preparation of radiolabeled micelles 
 
As previously described, about 5% of the PEG-PHEMA-PCMA monomers were conjugated 
with CB-TE2A.
22
 From these monomers, micelles were formed by dialysis. One single batch 
was prepared for in vivo studies, and this was split into two parts, where one was crosslinked 
by UV irradiation. For this reason, the only difference between the crosslinked (CL) and non-
crosslinked (nonCL) micelles, apart from slight differences in radiolabeling yield, would be 
the crosslinking. Successful crosslinking of the CL micelles was tested by measuring the drop 
in UV-absorbance at 320 nm, giving a degree of crosslinking (%CL) of 45% (Figure 2). In 
addition, crosslinking was verified by mixing the dispersions with dimethylformamide 
(DMF) in a micelle dispersion-to-DMF ratio of 1:16. Crosslinked micelles were found to be 
stable in DMF, exhibiting unchanged sizes (34 ± 4 nm) and PDI (0.059), while nonCL 
micelles were undetectable after mixing with DMF, with poorly defined sizes and PDIs and 
very low count rates comparable to background (< 10). Crosslinking was carried out at low 
temperature (5-7 
o
C) as we had observed that the elevated temperatures associated with 
irradiation could cause aggregation of certain micelle types. The CL and nonCL micelles 
were measured by DLS, giving hydrodynamic diameters for CL of 36 ± 2 nm (PDI: 0.04 ± 
0.01) and for nonCL of 36 ± 3 nm (PDI: 0.04 ± 0.01), and zeta potentials of -3.5 ± 0.3 mV 
(CL) and -3.8 ± 0.4 mV (nonCL). Accordingly, crosslinking was not observed to have 
significant influence on the physicochemical properties of the PMs.  
 
The CL and nonCL micelles were radiolabeled with 
64
Cu under identical circumstances with 
heating to 80 
o
C for 3 hours. Higher temperatures (95 
o
C) had been observed to cause 
aggregation of the micelles, and since 80 
o
C has previously been reported for 
64
Cu-labeling of 
CB-TE2A this temperature was used.
19
 After incubation with 
64
Cu, unincorporated 
radioactivity was scavenged by adding EDTA. EDTA (logK: 18.5) is a relatively weak 
chelator of Cu
2+
, but takes it up efficiently at room temperature. Scavenging is necessary as 
free 
64
Cu is known to accumulate in both tumors and liver,
25
 which are also intrinsic 
properties of nanoparticles.
22,26
 We had previously incubated PEG-PHEMA-PCMA 
monomers with no CB-TE2A with 
64
Cu for 3 hours at 80 
o
C and found that 17% of the 
radioactivity was associated with the micelles without EDTA scavenging, whereas 8% was 
associated after EDTA scavenging. It can be assumed that this number is lower with CB-
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TE2A conjugated micelles, as a large amount of the 
64
Cu will be taken up by the chelator. 
After EDTA scavenging, the radiolabeling efficiencies were, CL: 47% and NonCl: 40%. The 
micelle material concentrations upon injection were around 1.0 mg/mL for both micelle types 
with corresponding specific radioactivities (at injection) of 40-45 MBq/mg. 
 
 
3.2 In vivo PET/CT studies  
 
Both CL and nonCL versions of the 
64
Cu radiolabeled micelles were injected into the tail-
veins of tumor-bearing mice, followed by in vivo monitoring using PET/CT (Figure 3). 
Organ specific accumulation was quantified (Figure 4). Blood concentrations for both 
micelle types showed relatively long circulation times, with circulation half-lives on the order 
of 20 hours. Accordingly, the nonCL micelles were also long-circulating. At the 1 h time 
point (CL: 21.7 ± 4.2 %ID/g, nonCL: 18.4 ± 1.2 %ID/g), no statistically significant difference 
between the blood concentrations of CL and nonCL was observed (p = 0.116), but the 
tendency for lower blood concentration for nonCL became significant at 22 h (p = 0.016) and 
46 h (p = 0.004). However, this difference was not supported by the ex vivo data measured at 
48 h after injection (Figure 5), where no significant difference was observed between the 
blood concentrations of CL and nonCL (CL: 4.2 ± 0.8 %ID/g, nonCL: 4.0 ± 0.4 %ID/g, p = 
0.464). That a significant difference was observed only in the PET/CT images may be a 
consequence of the small size of the left ventricle, where partial volume effects could have 
influenced the PET readings. Consequently, it is reasonable to conclude that the two PM 
types followed similar courses of elimination from blood, with minor differences. Looking at 
the remaining organs, no significant differences between CL and nonCL were observed for 
liver, while all three measurement times showed significantly higher accumulation in spleen 
for CL compared to nonCL (p < 0.001). In the kidneys, only t = 22 h was significantly 
different (p = 0.020), while muscle and tumor had p-values above 0.05 for all measuring 
times. A similar picture was observed in the ex vivo data, where only tumor (p = 0.023) and 
spleen (p = 0.005) showed significant difference. Accordingly, our data suggests limited 
differences between the biodistributions of CL and nonCL, indicating that no pronounced 
advantage is obtained from crosslinking this type of PM. Although the data may hint at a 
marginally higher renal clearance for the nonCL PMs, this seems to hold little practical 
relevance for circulation times and tumor accumulation. The high stability of the nonCL 
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micelles may be related to the coumarin moieties forming glassy cores with high kinetic 
stability. 
In order to ensure that the observed similarity between the two micelle types was not simply a 
consequence of loss of 
64
Cu from the PMs, control experiments using 
64
Cu were carried out. 
64
CuCl2 was injected as a non-buffered saline solution (pH = 6.5) in which the 
64
Cu was 
stabilized in solution by ammonium acetate, in order to limit the formation of 
64
Cu-containing 
nanocolloids. Pronounced differences between the biodistributions of the free 
64
Cu and the 
PMs were observed. From the PET data (Figure 4) a fast elimination of the 
64
Cu from the 
circulation was observed (1 h = 3.0 ± 1.0 %ID/g), followed by a plateau concentration around 
2-3 %ID/g. This indicated that the 
64
Cu was quickly taken up by the organs, followed by 
serum trafficking on copper-carrying proteins, notably albumin and ceruloplasmin.
27
 As 
mentioned above, significantly slower elimination of the PMs from the circulation was 
observed. The primary accumulation organ for Cu is the liver,
27,28
 which was also observed 
for free 
64
Cu in our data, at a level that was significantly greater than for the PMs (1 h = 15.7 
± 1.2 %ID/g). That the 
64
Cu associated with the PMs was not cleared as rapidly and did not 
exhibit such high liver accumulation, supports that the 
64
Cu was bound to the micelles in both 
cases. The initial accumulation of the free 
64
Cu was followed by redistribution/elimination 
from the liver resulting in a drop in liver values that was faster than for the PMs. Splenic 
accumulation was limited for the free 
64
Cu and significantly lower than for the PMs. Since 
substantial splenic accumulation of nanoparticles is routinely observed,
29
 this observation 
also supports that the 
64
Cu was bound to the PMs. Interestingly, free 
64
Cu showed kidney 
accumulation similar to the PMs. 
64
Cu has previously been observed to accumulate in 
kidneys.
25
 Further, 
64
Cu has also been reported to independently accumulate in tumors,
25
 
possibly since Cu plays a role in tumor angiogenesis,
30
 which we also observed in this study. 
The tumor accumulation of free 
64
Cu was comparable to the micelles, but in contrast to the 
PMs which showed a steady accumulation, the 
64
Cu showed high initial accumulation (1 h = 
4.4 ± 1.8 %ID/g), followed by a slight, though statistically insignificant, drop in values.   
 
In summary, it appears that the nonCL micelles exhibit excellent stability in circulation, in 
spite of the lack of crosslinking, resulting in circulation times that are on par with the 
crosslinked variant. It is often assumed that crosslinking improves the pharmacokinetic 
profile of polymeric micelles by making them longer circulating and thereby enhancing 
tumor accumulation by the EPR-effect. In this study, we showed that this is not always the 
case in an in vivo setting, at least for 4-methylcoumarin based systems. It should be noted that 
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the unimers employed here only contained 18 repeats of the 4-methylcoumarin unit and the 
stabilizing lipid domain was thus relatively short. We also demonstrated the usefulness of 
PET imaging when investigating the in vivo effect of modifications to polymeric micelles, 
such as crosslinking. The results presented here are interesting since the presence of single 
unimers without crosslinking is often preferable to cross-linked micelles, provided that the 
micelles exhibit sufficient kinetic stability in circulation. As the threshold for renal clearance 
is < 10 nm,
31
 single unimers are more easily cleared than crosslinked micelles, requiring only 
disintegration, rather than chemical degradation. Although coumarin-containing micelles can 
be de-crosslinked by light exposure, UV light cannot reach deep tissues, and is therefore 
generally not useful for micelle de-crosslinking after organ accumulation in the clinical 
setting.
32
 Slow clearance of therapeutically administered crosslinked polymeric micelles can 
potentially result in accumulation of nanoparticulate material with so far poorly understood 
consequences. In addition, much recent methodology is based on disintegration of micelles as 
a response to pH changes.
33
 Such methods can only be used if the unimers are held together 
by relatively weak hydrophobic interactions and the breaking of chemicals bonds from 
crosslinking is not required. Finally, we observed that the crosslinking step can confer some 
instability to the PMs if not carefully controlled, making it preferable to totally omit this step, 
especially when scaling up the manufacturing process.  
 
 
4 Conclusions 
 
In this study we compared the in vivo biodistribution of non-crosslinked polymeric micelles 
containing a core consisting of 18 repeats of 4-methylcoumarin with their crosslinked 
counterparts. The biodistributions of the two micelle types showed limited differences that 
can be considered negligible in a nanomedicine context. This was demonstrated against 
control injections of free 
64
Cu, which showed substantial tumor accumulation but differed 
markedly from the micelles in key organs, notably liver and spleen, as well as bloodstream 
concentrations. These findings are significant in that omitting crosslinking is often preferable 
in drug delivery due to easier clearance, less cumbersome preparation and more freedom in 
release strategies. Further, the demonstrated methodology showcases a general nuclear 
imaging technique that can be utilized for in vivo investigation of micelle stability for a range 
of PM types. 
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Figure 1. Concept drawing of crosslinking and composition of polymeric micelles. The 
triblock PEG-PHEMA-PCMA micelle unimers are shown in three colors, with yellow 
representing the hydrophobic core (PCMA), red the handle domain with CB-TE2A attached 
(PHEMA) and black the outer hydrophilic PEG domain. (a) Non-crosslinked, non-
radiolabeled micelle, (b) Crosslinked, non-radiolabeled micelle, (c) Non-crosslinked micelle, 
radiolabeled with 
64
Cu (nonCL), (d) Crosslinked micelle, radiolabeled with 
64
Cu (CL), (e) 
Photo-induced crosslinking reaction between two 4-methylcoumarin moieties, (f) Structure of 
the CB-TE2A chelator, (g) Structure of the PEG-PHEMA-PCMA unimer, consisting of 18 
coumarin repeats, 7 functionalizable alcohol repeats with one conjugated CB-TE2A, and 127 
PEG repeats.      
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Figure 2. UV chromatograms of polymeric micelles before (NonCL) and after (CL) 
crosslinking for 30 minutes at 2 W/cm
2
 (320−500 nm). The degree of crosslinking was 
measured as the drop in absorbance of the 320 nm maximum from 0.664 to 0.366 giving 
%CL = 45%.    
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Figure 3. Fused PET/CT images of the crosslinked (CL, upper panel) and non-crosslinked 
(nonCL, middle panel) polymeric micelles. In the lower panel (
64
CuCl2) is shown the 
biodistribution of free 
64
Cu, included as control experiment. The studies were conducted in 
mice with U87MG tumor xenografts on both flanks. Tumors (T), liver (L), spleen (S), 
bladder (B) and intestine (I) are marked on the images. The images revealed gradual 
accumulation in liver, spleen and tumors for the two micelle types, compared to rapid (1 h) 
accumulation of the free 
64
Cu in the liver, followed by tumor accumulation. 
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Figure 4 Mean tissue accumulation based on PET/CT imaging at 1 h, 22 h and 46 h after 
injection, given as %ID/g ± SD. Crosslinked polymeric micelles (CL) are shown in blue, non-
crosslinked polymeric micelles (nonCL) is shown in red, free 
64
Cu
2+
 is shown in green. 
Significant difference as per Students’ T-test is shown as p > 0.05 (-), 0.05 > p > 0.01 (*), 
0.01 > p > 0.001  (**), p < 0.001 (***). Markings in black show p-value comparison between 
CL and nonCL, markings in blue and red show comparison of free 
64
Cu with CL or with 
nonCL, respectively. n = 5 for nonCL and 
64
CuCl2 (tumors, n = 10) and n = 6 for CL (tumors, 
n = 12). 
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Figure 5 Mean tissue accumulation based on excised organs at 48 h after injection, given as 
%ID/g ± SD. Crosslinked polymeric micelles (CL) are shown in blue, non-crosslinked 
polymeric micelles (nonCL) are shown in red, free 
64
Cu
2+
 is shown in green. Significant 
difference as per Students’ T-test is shown as p > 0.05 (-), 0.05 > p > 0.01 (*), 0.01 > p > 
0.001 (**), p < 0.001 (***). Markings in black show p-value comparison between CL and 
nonCL, markings in blue and red show comparison of free 
64
Cu with CL or with nonCL, 
respectively. n = 5 for nonCL and 
64
CuCl2 (tumors, n = 10) and n = 4 for CL (tumors, n = 8).   
 
